The FDA approved Bayer’s Kerendia for reducing the risk of heart failure in patients with mildly reduced ejection fraction, a measure of how much blood the organ can pump. The daily pill was first approved in 2021 for patients with chronic kidney disease associated with type 2 diabetes. The post Bayer’s Blockbuster Hopeful Kerendia Expands…
When Matthew Hurley was looking to take PrEP to prevent HIV, the doctor hadn’t heard of the medicine, and when he finally did prescribe PrEP, the bills sent to Hurley were expensive … and wrong. “I decided to write in because the process was really super frustrating.” At one point, Hurley asked, “Am I just…
Boo! We scared you. Now it’s your turn to give our newsroom a scare. Submissions are now open for KFF Health News’ sixth annual Halloween haiku competition. KFF Health News has been publishing reader-submitted health care haikus for years and is on pins and needles to read how this spooky season inspires you. We want…
Access to care isn’t enough. Healthcare organizations need to build trust in order to reach underserved communities, experts said on a recent panel. The post How Can Healthcare Organizations Earn Trust with Marginalized Communities? appeared first on MedCity News.
The Peterson Health Technology Institute outlined five key recommendations for employers seeking to design sustainable GLP-1 coverage. The post PHTI: How Employers Can Manage GLP-1 Coverage appeared first on MedCity News.
KFF Health News chief Washington correspondent Julie Rovner discussed President-elect Donald Trump’s announcement that he will nominate former TV host Mehmet Oz to lead the Centers for Medicare & Medicaid Services on WBUR’s “Here & Now” on Nov. 20. Rovner also discussed what it could mean for Robert F. Kennedy Jr. to run the Department…
Tory Starr is worried about the people who get medical care at Open Door Community Health Centers along California’s North Coast. “They’re the folks that work at restaurants. They’re the teacher’s aides,” said Starr, a registered nurse who became Open Door’s chief executive more than six years ago. Those patients, he said, are “really the…
Bristol Myers Squibb’s new multibillion-dollar partnership in a hot area of cancer research overshadowed many of the announcements at the recent annual meeting of the American Society of Clinical Oncology in Chicago. We covered that news and other developments from the largest cancer conference in the world. The post ASCO 2025 Recap: Rise of the…
LADUE, Mo. — Over four consecutive days in January, Margaret Hvatum ran a 5K, a 10K, a half-marathon, and a full marathon. The 70-year-old covered a combined distance that’s nearly equivalent to running the length of Manhattan four times. By the end of the month, she was in a hospital bed. Hvatum, a part-time computer…
AI built on transparent, causal reasoning, systems that ground every output in validated biological mechanisms, show the pathway behind each recommendation, and cite their sources is what makes the difference between a tool that erodes clinical trust and one that rebuilds it. The post Why Generative AI Isn’t Enough: The Case for Causal Reasoning in…